Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

Andrea Antinori; Francesco Baldini; Enrico Girardi; Antonella Cingolani; Mauro Zaccarelli; Simona Di Giambenedetto; Annalisa Barracchini; Patrizio De Longis; Rita Murri; Valerio Tozzi; Adriana Ammassari; Maria Gabriella Rizzo; Giuseppe Ippolito; Andrea De Luca

doi:10.1097/00002030-200108170-00018

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

Andrea Antinori, Francesco Baldini, Enrico Girardi, Antonella Cingolani, Mauro Zaccarelli, Simona Di Giambenedetto, Annalisa Barracchini, Patrizio De Longis, Rita Murri, Valerio Tozzi, Adriana Ammassari, Maria Gabriella Rizzo, Giuseppe Ippolito, Andrea De Luca

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article

Abstract

To identify factors associated with cutaneous rash, we performed a retrospective multicentre analysis of HIV outpatients starting a highly active antiretroviral therapy regimen containing nevirapine. A total of 62 cutaneous adverse events were observed in 429 patients. Rash hazard was increased in women, by the prophylactic use of glucocorticoids or antihistaminics, and was reduced by escalating the initial dose of nevirapine. Women receiving glucocorticoids had a 3 month cumulative probability of rash of 0.41.

Original language	English
Pages (from-to)	1579-1581
Number of pages	3
Journal	AIDS (London, England)
Volume	15
Issue number	12
DOIs	https://doi.org/10.1097/00002030-200108170-00018
Publication status	Published - Aug 17 2001

Fingerprint

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Cite this

Antinori, A., Baldini, F., Girardi, E., Cingolani, A., Zaccarelli, M., Di Giambenedetto, S., Barracchini, A., De Longis, P., Murri, R., Tozzi, V., Ammassari, A., Rizzo, M. G., Ippolito, G., & De Luca, A. (2001). Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy. AIDS (London, England), 15(12), 1579-1581. https://doi.org/10.1097/00002030-200108170-00018

Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy. / Antinori, Andrea ; Baldini, Francesco ; Girardi, Enrico; Cingolani, Antonella; Zaccarelli, Mauro; Di Giambenedetto, Simona; Barracchini, Annalisa; De Longis, Patrizio; Murri, Rita; Tozzi, Valerio; Ammassari, Adriana; Rizzo, Maria Gabriella; Ippolito, Giuseppe; De Luca, Andrea.

In: AIDS (London, England), Vol. 15, No. 12, 17.08.2001, p. 1579-1581.

Research output: Contribution to journal › Article

Antinori, A , Baldini, F , Girardi, E, Cingolani, A, Zaccarelli, M, Di Giambenedetto, S, Barracchini, A, De Longis, P, Murri, R, Tozzi, V, Ammassari, A, Rizzo, MG, Ippolito, G & De Luca, A 2001, 'Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy', AIDS (London, England), vol. 15, no. 12, pp. 1579-1581. https://doi.org/10.1097/00002030-200108170-00018

Antinori, Andrea ; Baldini, Francesco ; Girardi, Enrico ; Cingolani, Antonella ; Zaccarelli, Mauro ; Di Giambenedetto, Simona ; Barracchini, Annalisa ; De Longis, Patrizio ; Murri, Rita ; Tozzi, Valerio ; Ammassari, Adriana ; Rizzo, Maria Gabriella ; Ippolito, Giuseppe ; De Luca, Andrea. / Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy. In: AIDS (London, England). 2001 ; Vol. 15, No. 12. pp. 1579-1581.

@article{c4207cfa89ad40508543f1efa216fe61,

title = "Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy",

abstract = "To identify factors associated with cutaneous rash, we performed a retrospective multicentre analysis of HIV outpatients starting a highly active antiretroviral therapy regimen containing nevirapine. A total of 62 cutaneous adverse events were observed in 429 patients. Rash hazard was increased in women, by the prophylactic use of glucocorticoids or antihistaminics, and was reduced by escalating the initial dose of nevirapine. Women receiving glucocorticoids had a 3 month cumulative probability of rash of 0.41.",

author = "Andrea Antinori and Francesco Baldini and Enrico Girardi and Antonella Cingolani and Mauro Zaccarelli and {Di Giambenedetto}, Simona and Annalisa Barracchini and {De Longis}, Patrizio and Rita Murri and Valerio Tozzi and Adriana Ammassari and Rizzo, {Maria Gabriella} and Giuseppe Ippolito and {De Luca}, Andrea",

year = "2001",

month = aug

day = "17",

doi = "10.1097/00002030-200108170-00018",

language = "English",

volume = "15",

pages = "1579--1581",

journal = "AIDS",

issn = "0269-9370",

publisher = "NLM (Medline)",

number = "12",

}

TY - JOUR

T1 - Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy

AU - Antinori, Andrea

AU - Baldini, Francesco

AU - Girardi, Enrico

AU - Cingolani, Antonella

AU - Zaccarelli, Mauro

AU - Di Giambenedetto, Simona

AU - Barracchini, Annalisa

AU - De Longis, Patrizio

AU - Murri, Rita

AU - Tozzi, Valerio

AU - Ammassari, Adriana

AU - Rizzo, Maria Gabriella

AU - Ippolito, Giuseppe

AU - De Luca, Andrea

PY - 2001/8/17

Y1 - 2001/8/17

N2 - To identify factors associated with cutaneous rash, we performed a retrospective multicentre analysis of HIV outpatients starting a highly active antiretroviral therapy regimen containing nevirapine. A total of 62 cutaneous adverse events were observed in 429 patients. Rash hazard was increased in women, by the prophylactic use of glucocorticoids or antihistaminics, and was reduced by escalating the initial dose of nevirapine. Women receiving glucocorticoids had a 3 month cumulative probability of rash of 0.41.

AB - To identify factors associated with cutaneous rash, we performed a retrospective multicentre analysis of HIV outpatients starting a highly active antiretroviral therapy regimen containing nevirapine. A total of 62 cutaneous adverse events were observed in 429 patients. Rash hazard was increased in women, by the prophylactic use of glucocorticoids or antihistaminics, and was reduced by escalating the initial dose of nevirapine. Women receiving glucocorticoids had a 3 month cumulative probability of rash of 0.41.

UR - http://www.scopus.com/inward/record.url?scp=0035903010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035903010&partnerID=8YFLogxK

U2 - 10.1097/00002030-200108170-00018

DO - 10.1097/00002030-200108170-00018

M3 - Article

C2 - 11504993

AN - SCOPUS:0035903010

VL - 15

SP - 1579

EP - 1581

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 12

ER -

Access to Document

10.1097/00002030-200108170-00018